This Article Full Text Full Text (PDF) eLetters: Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brown, J. R. Articles by Skarin, A. T. Search for Related Content PubMed PubMed Citation Articles by Brown, J. R. Articles by Skarin, A. T.

Clinical Mimics of Lymphoma

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA

Correspondence: Arthur T. Skarin, M.D., Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA. Telephone: 617-632-3468; Fax: 617-632-4379; e-mail: arthur_skarin{at}dfci.harvard.edu

Lymphadenopathy is a common clinical finding and is frequently benign. Warning signs suggestive of a malignant etiology include lymph nodes >2 cm in size, supraclavicular location, and generalized lymphadenopathy associated with hepatosplenomegaly or systemic symptoms. A metastatic solid tumor is always in the differential diagnosis of localized lymphadenopathy, particularly in older individuals. In the case of more generalized lymphadenopathy, in addition to the more common lymphomas, benign etiologies as well as benign and atypical lymphoproliferative disorders need to be considered. Benign etiologies of lymphadenopathy can include infections, autoimmune disorders, drug hypersensitivity reactions, sarcoidosis, and amyloidosis. Rare but benign lymphoproliferative disorders include Kikuchi’s disease, Rosai-Dorfman disease, and progressive transformation of germinal centers. Atypical lymphoproliferative disorders that bear close surveillance for evolution to a more aggressive malignancy include Castleman’s disease, lymphomatoid granulomatosis, and lymphomatoid papulosis. Previously considered in this category but now classified as a true lymphoma is angioimmunoblastic lymphadenopathy with dysproteinemia. Physicians need to be aware of all of these disorders when evaluating suspicious lymphadenopathy, while also considering the more common lymphomas and leukemias.

Key Words. Lymphadenopathy • Lymphoma • Castleman’s disease • Lymphomatoid granulomatosis • Kikuchi’s disease

This article has been cited by other articles:

				R. Gruber, N. T. Sepp, P. O. Fritsch, and M. Schmuth Prognosis of Lymphomatoid Papulosis Oncologist, September 1, 2006; 11(8): 955 - 957. [Full Text] [PDF]

				H. Alatassi, M. B. Ray, S. Galandiuk, and S. Sahoo Rosai-Dorfman Disease of the Gastrointestinal Tract: Report of a Case and Review of the Literature International Journal of Surgical Pathology, January 1, 2006; 14(1): 95 - 99. [Abstract] [PDF]